Found: 5
Select item for more details and to access through your institution.
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain.
- Published in:
- British Journal of Clinical Pharmacology, 2007, v. 64, n. 1, p. 75, doi. 10.1111/j.1365-2125.2007.02880.x
- By:
- Publication type:
- Article
Effect of 4-Year Antioxidant Treatment with α-Lipoic Acid in Diabetic Polyneuropathy: The NATHAN 1 Trial.
- Published in:
- Diabetes, 2007, v. 56, p. A2
- By:
- Publication type:
- Article
Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy.
- Published in:
- Diabetes Care, 2011, v. 34, n. 9, p. 2054, doi. 10.2337/dc11-0503
- By:
- Publication type:
- Article
Challenges in Design of Multicenter Trials.
- Published in:
- Diabetes Care, 2007, v. 30, n. 10, p. 2619, doi. 10.2337/dc06-2479
- By:
- Publication type:
- Article
The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article